
Collins Stewart
http://www.collins-stewart.com/index.aspCollins Stewart is an independent investment banking group.
View Older Stories
-
Collins Stewart Maintains a 'Neutral' on Human Genome Sciences (HGSI); Review of Benlysta Sales
-
Collins Stewart maintains a 'Sell' on Amylin Pharmaceuticals (AMLN); Bydureon Now Has 2% Market Share
-
YM BioSciences (YMI) Closes 35M Offering at $2/Share
-
Collins Stewart Downgrades Cablevision (CVC) to Neutral
-
Q4 Preview: First Solar (FSLR) Investors Eye Europe, But India Might Be Key
-
Collins Stewart Maintains a 'Neutral' on Sprint (S); No Deal? Possible Negative for Towers
-
Following Q1 Results, Analysts Say HP's (HPQ) Multi-Year Turnaround Has Not Yet Begun
-
Notable Analyst Rating Changes 02/23: (DTV) (LVLT) (ERIC) Upgraded; (ITRI) (WPRT) (HGSI) Downgraded
-
Collins Stewart Downgrades Human Genome Sciences (HGSI) to Neutral; Survey Suggests Lackluster 2012
-
HDD Costs, Low Demand Hamper Dell's (DELL) Q4 Results, Outlook; Analysts Comment
-
Q4 Preview: It's No Secret Limited Brands (LTD) Has Strong Momentum
-
Collins Stewart Raises Price Target on Home Depot (HD) Following Solid Q4 Results and FY12 Guidance
-
Top 10 News Items 2/13-2/17: Apple Breaks $500 Level; Greece Awaits Euro Leader Meeting on Bailout; Earnings Move Stocks Sharply
-
Solar Stocks Rocket Higher as News from Top Players Turning Positive
-
Morning Movers 02/17: (CTIC) (SPWR) (RAIL) (ACHN) Higher; (ARTC) (RP) (GILD) (RMTR) Lower